MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms (PARIS-D)
Pilot Study of Mindfulness-Based Stress Reduction (MBSR) in Patients With Rheumatoid Arthritis That Still Screen Depressed, Despite Adequate Control of Inflammation
Sponsor: Canadian Initiative for Outcomes in Rheumatology Care
Listed as NCT03514355, this NA trial focuses on Depressive Symptoms and Rheumatoid Arthritis and remains completed. Sponsored by Canadian Initiative for Outcomes in Rheumatology Care, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
▶ Show 3 earlier versions
-
May 2019 — Jul 2020 [monthly]
Enrolling By Invitation NA
-
Nov 2018 — May 2019 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Nov 2018 [monthly]
Enrolling By Invitation NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Initiative for Outcomes in Rheumatology Care
- Université de Sherbrooke
For direct contact, visit the study record on ClinicalTrials.gov .